Cargando…
Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection
Despite the availability of an effective prophylactic vaccine leading to sterilizing immunity, hepatitis B virus (HBV) is responsible for chronic liver disease in more than 250 million individuals, potentially leading to cirrhosis and hepatocellular carcinoma. Antiviral drugs able to completely supp...
Autores principales: | Cerino, Antonella, Mantovani, Stefania, Mele, Dalila, Oliviero, Barbara, Varchetta, Stefania, Mondelli, Mario U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773823/ https://www.ncbi.nlm.nih.gov/pubmed/31608071 http://dx.doi.org/10.3389/fimmu.2019.02290 |
Ejemplares similares
-
Natural killer cell functional dichotomy: a feature of chronic viral hepatitis?
por: Mondelli, Mario U., et al.
Publicado: (2012) -
High Frequencies of Functional Virus-Specific CD4(+) T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders
por: Mele, Dalila, et al.
Publicado: (2021) -
Expansion of atypical memory B cells is a prominent feature of COVID-19
por: Oliviero, Barbara, et al.
Publicado: (2020) -
Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches
por: Mantovani, Stefania, et al.
Publicado: (2020) -
Impaired intratumoral natural killer cell function in head and neck carcinoma
por: Mele, Dalila, et al.
Publicado: (2022)